ClinicalTrials.govpublic full text
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)
relapsing-remitting multiple sclerosis, evobrutinib, avonex®, interferon-beta 1a, relapsing multiple sclerosis, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847438
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.